12/20/2024
4:01 PM | Sonoma Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/21/2024
3:01 PM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
7:36 AM | Sonoma Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/22/2024
7:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
5:00 AM | Sonoma Pharmaceuticals (Filer)
| Form 424B5 | |
09/20/2024
5:02 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
5:03 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/21/2024
7:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:49 PM | Sonoma Pharmaceuticals (Filer)
| Form DEFA14A | |
08/14/2024
7:53 PM | Sonoma Pharmaceuticals (Filer)
| Form DEFA14A | |
07/24/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form DEFA14A | |
07/01/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form DEF 14A | |
06/27/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 424B5 | |
06/27/2024
6:31 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:56 PM | Sonoma Pharmaceuticals (Filer)
| Form PRE 14A | |
06/21/2024
4:05 PM | Dal Poggetto John (Reporting)
Sonoma Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:05 PM | DVONCH JEROME J (Reporting)
Sonoma Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:05 PM | Sonoma Pharmaceuticals (Issuer)
Thornton Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:06 PM | Sonoma Pharmaceuticals (Issuer)
Trombly Amy Moss (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
3:30 PM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
6:30 AM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
3:47 PM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:23 PM | Sonoma Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:24 PM | DVONCH JEROME J (Reporting)
Sonoma Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:25 PM | Dal Poggetto John (Reporting)
Sonoma Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:25 PM | Sonoma Pharmaceuticals (Issuer)
Thornton Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:26 PM | Sonoma Pharmaceuticals (Issuer)
Trombly Amy Moss (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
